Portfolio Advancing Portfolio Screening Program RFP Year2020 Awarded Amount $118,300 DiseaseTuberculosis InterventionDrug Development Stage Hit Identification Collaboration Partners Daiichi Sankyo RD Novare Co., Ltd., The Global Alliance for TB Drug Development